购物车
- 全部删除
- 您的购物车当前为空
Anti-KLK3 Monoclonal Antibody-Biotin is a Biotin-conjugated rabbit antibody targeting KLK3. Anti-KLK3 Monoclonal Antibody-Biotin can be used in ELISA, FACS, IF.
Anti-KLK3 Monoclonal Antibody-Biotin is a Biotin-conjugated rabbit antibody targeting KLK3. Anti-KLK3 Monoclonal Antibody-Biotin can be used in ELISA, FACS, IF.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 μg | ¥ 1,955 | 7日内发货 | |
50 μg | ¥ 3,258 | 7日内发货 | |
100 μg | ¥ 4,887 | 7日内发货 |
产品描述 | Anti-KLK3 Monoclonal Antibody-Biotin is a Biotin-conjugated rabbit antibody targeting KLK3. Anti-KLK3 Monoclonal Antibody-Biotin can be used in ELISA, FACS, IF. |
别名 | Semenogelase, Prostate-specific antigen, P-30 antigen, Kallikrein-3, Gamma-seminoprotein |
Ig Type | Rabbit monoclonal IgG |
交叉反应 | Human |
验证活性 | Flow cytometry analysis of KLK3 overexpressed 356F cells with TMAZ-0177B, followed by goat anti-rabbit IgG-ABflo 647 (red line). The isotype control is rabbit IgG (black line). |
应用 | ELISA, FACS, IF |
推荐剂量 | 0.1-0.2 μg/10E6 cells for FACS; 1 ng/μl for ELISA |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
亚细胞定位 | Secreted |
构建方式 | This antibody was produced from a rabbit immunized with purified, recombinant human extracellular domain of KLK3 protein. |
纯化方式 | Protein A Affinity Purified |
性状 | Liquid |
缓冲液 | 0.22 μm filtered solution in 20 mM HEPES7.4, 150 mM NaCl, 50% glycerol and 0.03% proclin. |
纯度 | > 95% as determined by SDS-PAGE. |
研究背景 | Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum |
偶联 | Biotin |
其他可选修饰符 | APC/PE/AF488/AF555/AF647 |
可提供抗体种类 | 1 |
免疫原 | KLK3 |
抗原种属 | Human |
基因ID | 354 |
Uniprot ID | |
研究领域 | Drug Target |
分子量 | 150 kDa |
储存方式 | For unconjugated and biotin antibody, store at -20°C or -80°C for long term. Avoid repeated freeze-thaw cycles. For APC/PE/AF647/AF555/AF488 conjugated antibody, store at 4°C, do not freeze. |
运输方式 | For unconjugated and biotin antibody, shipping with dry ice. For APC/PE/AF647/AF555/AF488 conjugated antibody, shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容